...
Dryness & GSM faq

Can long-term cycling or friction make dryness worse?

Yes. Can long-term cycling or friction make dryness worse? Repeated pressure, heat and rubbing from saddles, tight kit or long walks can aggravate the thin, less lubricated tissues seen in genitourinary syndrome of menopause (GSM). This may increase burning, itching and micro-tears (especially at the entrance), and trigger flares after exercise or sex. Protective clothing choices, gentle vulval care, regular moisturisers and the right lubricant reduce friction; local oestrogen or DHEA may help persistent symptoms. Educational only. Results vary. Not a cure.

Clinical Context

Who may be most affected by friction? Long-distance cyclists or spin enthusiasts; runners or hikers wearing snug, moisture-retaining kit; and anyone with existing GSM, especially after surgical menopause or in those who cannot/choose not to use systemic HRT. Sensitive skin, a history of dermatitis, or conditions like lichen sclerosus increase fragility. Early clues include stinging with urine on delicate skin, a scratchy feel during walks, or spotting after sex from superficial fissures.

Who should seek review first? Anyone with persistent dyspareunia, new or malodorous discharge, fever, pelvic pain, visible ulcers/white plaques, post-menopausal bleeding, or visible blood in urine should be assessed to exclude infection, dermatological disease, or other causes. For those avoiding hormones, non-hormonal care—scheduled moisturisers (often with hyaluronic acid), tailored lubricants, gentle vulval care—remains useful; pelvic floor physiotherapy and psychosexual strategies reduce fear-avoidance patterns when pain has set in. Plan a 6–12-week review to adjust to the lowest effective maintenance once symptoms settle.

Evidence-Based Approaches

Guideline-aligned care starts with non-hormonal support and escalates thoughtfully. The NICE Menopause Guideline (NG23) recommends offering information on moisturisers and lubricants and considering low-dose local vaginal oestrogen for GSM. NHS pages on vaginal dryness and dyspareunia provide practical self-care and red-flag advice. Cochrane reviews indicate local oestrogens improve dryness, soreness and dyspareunia with low systemic absorption at licensed doses; see the Cochrane Library for pooled estimates.

For mimics and co-morbid dermatoses, the British Association of Dermatologists offers diagnostic pointers. For an overview of GSM mechanisms and options (local oestrogen, vaginal DHEA, pelvic floor and psychosexual therapy), see peer-reviewed summaries indexed on PubMed. In practice, reducing friction load (kit, fit, hygiene), building reliable moisturiser/lubricant routines, and adding local hormonal therapy when needed provide the strongest evidence-based foundation; reserve device-based or injectable treatments for selected cases after shared decision-making.